Alemtuzumab/iodine-131Graves' disease and Graves' orbitopathy: 6 case reports

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-019-58708-8
中图分类号
学科分类号
摘要
引用
收藏
页码:20 / 20
相关论文
共 50 条
  • [42] Death by Suicide in Graves' Disease and Graves' Orbitopathy: A Nationwide Danish Register Study
    Ferlov-Schwensen, Charlotte
    Brix, Thomas Heiberg
    Hegedues, Laszlo
    THYROID, 2017, 27 (12) : 1475 - 1480
  • [43] Serum thyroglobulin is associated with orbitopathy in Graves’ disease
    S. Khamisi
    M. Lundqvist
    P. Emadi
    K. Almby
    Ö. Ljunggren
    F. A. Karlsson
    Journal of Endocrinological Investigation, 2021, 44 : 1905 - 1911
  • [44] Guidance on That Damned Elusive Orbitopathy of Graves' Disease
    Laurberg, Peter
    EUROPEAN THYROID JOURNAL, 2016, 5 (01) : 4 - 6
  • [45] Teprotumumab: a disease modifying treatment for graves' orbitopathy
    Ting, Michelle
    Ezra, Daniel G.
    THYROID RESEARCH, 2020, 13 (01)
  • [46] ORBITOPATHY AFTER TREATMENT OF GRAVES-DISEASE
    HURLEY, JR
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : 918 - 920
  • [47] Graves' Orbitopathy: Imperfect Treatments for a Rare Disease
    Bartalena, Luigi
    EUROPEAN THYROID JOURNAL, 2013, 2 (04) : 259 - 269
  • [48] Serum thyroglobulin is associated with orbitopathy in Graves' disease
    Khamisi, S.
    Lundqvist, M.
    Emadi, P.
    Almby, K.
    Ljunggren, O.
    Karlsson, F. A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (09) : 1905 - 1911
  • [49] Graves Disease Presenting With Advanced Orbitopathy and Acropachy
    Azam, Zaki Y.
    Palazzolo, Laura
    Shinder, Roman
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2020, 36 (02): : E56 - E56
  • [50] Teprotumumab: a disease modifying treatment for graves’ orbitopathy
    Michelle Ting
    Daniel G. Ezra
    Thyroid Research, 13